Patriot Investment Management Inc. Nu Cana PLC Transaction History

Patriot Investment Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Oct 23, 2020	SELL	$4.57 - $6.48 $228 - $324	-50 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$4.87 - $7.37 $243 - $368	50 New	50 $0

3.34M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $112M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Patriot Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Patriot Investment Management Inc. with notifications on news.